Key Points
- Cosmos Health CEO Grigorios Siokas purchased 88,314 shares on Dec. 19 at $0.49 each for $43,273.86, raising his stake to 6,716,771 shares (a 1.33% increase).
- Siokas has made multiple recent purchases (several hundred thousand shares from Nov. 19–Dec. 15), signaling continued insider accumulation of NASDAQ:COSM stock.
- Despite the insider buying, Cosmos Health has weak fundamentals—reported a (-$0.17) EPS that missed estimates, a negative return on equity, a market cap of about $18.5M, and an average analyst rating of "Sell".
Cosmos Health Inc. (NASDAQ:COSM - Get Free Report) CEO Grigorios Siokas bought 88,314 shares of the company's stock in a transaction on Friday, December 19th. The shares were bought at an average cost of $0.49 per share, for a total transaction of $43,273.86. Following the transaction, the chief executive officer owned 6,716,771 shares in the company, valued at $3,291,217.79. The trade was a 1.33% increase in their position. The acquisition was disclosed in a filing with the SEC, which is available through this link.
Grigorios Siokas also recently made the following trade(s):
- On Monday, December 15th, Grigorios Siokas purchased 168,472 shares of Cosmos Health stock. The stock was bought at an average cost of $0.42 per share, with a total value of $70,758.24.
- On Friday, November 28th, Grigorios Siokas acquired 76,360 shares of Cosmos Health stock. The shares were bought at an average price of $0.64 per share, with a total value of $48,870.40.
- On Tuesday, November 25th, Grigorios Siokas acquired 55,732 shares of Cosmos Health stock. The shares were bought at an average cost of $0.63 per share, for a total transaction of $35,111.16.
- On Friday, November 21st, Grigorios Siokas bought 56,080 shares of Cosmos Health stock. The stock was purchased at an average price of $0.68 per share, with a total value of $38,134.40.
- On Thursday, November 20th, Grigorios Siokas bought 51,315 shares of Cosmos Health stock. The stock was purchased at an average price of $0.62 per share, with a total value of $31,815.30.
- On Wednesday, November 19th, Grigorios Siokas purchased 61,614 shares of Cosmos Health stock. The shares were purchased at an average price of $0.65 per share, for a total transaction of $40,049.10.
Cosmos Health Stock Up 8.9%
Cosmos Health stock opened at $0.53 on Tuesday. The business's 50-day simple moving average is $0.71 and its two-hundred day simple moving average is $0.72. The company has a debt-to-equity ratio of 0.25, a quick ratio of 0.84 and a current ratio of 0.99. The company has a market cap of $18.51 million, a PE ratio of -0.71 and a beta of 5.34. Cosmos Health Inc. has a fifty-two week low of $0.28 and a fifty-two week high of $1.32.
Cosmos Health (NASDAQ:COSM - Get Free Report) last released its earnings results on Friday, November 14th. The company reported ($0.17) EPS for the quarter, missing analysts' consensus estimates of ($0.01) by ($0.16). The firm had revenue of $17.11 million for the quarter, compared to analyst estimates of $16.40 million. Cosmos Health had a negative return on equity of 33.19% and a negative net margin of 31.01%. Equities analysts anticipate that Cosmos Health Inc. will post -0.78 EPS for the current year.
Wall Street Analysts Forecast Growth
A number of analysts have recently weighed in on COSM shares. Wall Street Zen upgraded shares of Cosmos Health to a "hold" rating in a research note on Saturday, September 20th. Weiss Ratings reaffirmed a "sell (d-)" rating on shares of Cosmos Health in a report on Wednesday, October 8th. One equities research analyst has rated the stock with a Sell rating, According to MarketBeat, the stock currently has an average rating of "Sell".
View Our Latest Research Report on COSM
Hedge Funds Weigh In On Cosmos Health
An institutional investor recently raised its position in Cosmos Health stock. Armistice Capital LLC boosted its position in shares of Cosmos Health Inc. (NASDAQ:COSM - Free Report) by 156.1% during the 1st quarter, according to the company in its most recent disclosure with the SEC. The firm owned 1,917,710 shares of the company's stock after buying an additional 1,168,884 shares during the quarter. Armistice Capital LLC owned approximately 7.03% of Cosmos Health worth $836,000 at the end of the most recent reporting period. Institutional investors and hedge funds own 12.61% of the company's stock.
Cosmos Health Company Profile
(
Get Free Report)
Cosmos Health Inc manufactures, develops, and trades branded nutraceutical products in Greece, the United Kingdom, Croatia, Bulgaria, Cayman Islands, and Cyprus. It offers medicines, OTC medicines, nutraceutical products, vitamins, minerals and dietary, health care products, medical devices, baby products, and others under the Sky Premium Life and Mediterranation brand names. The company serves wholesale distributors and other healthcare providers, such as clinics, government agencies, independent retail and specialty pharmacies and independent specialty distributors.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
